Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | ANPEP | P15144 | 2/20 | 0.53 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.53 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Phenylalanine SCHEMBL6450960 | 1.00 | SLC7A5 (0.58) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL29503517 | 0.92 | SLC7A5 (0.69) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL28076342 | 0.92 | SLC7A5 (0.69) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL464777 | 0.92 | SLC7A5 (0.69) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL464776 | 0.92 | SLC7A5 (0.69) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL28231547 | 0.92 | SLC7A5 (0.69) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL5503585 | 0.91 | ALPI (0.48) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL15323164 | 0.91 | SLC7A5 (0.48) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL6454258 | 0.91 | SLC7A5 (0.48) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL6454263 | 0.91 | SLC7A5 (0.48) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1800692-B1 | Immunological compositions and vaccines containing N-formyl methionyl peptide as adjuvant | CONNAUGHT TECHNOLOGY CORP (US) | 2011-01-26 | — | — | EP | claimed |
| EP-1800692-A1 | Novel adjuvant for subunit or component vaccines | Connaught Technology Corporation (US) | 2007-06-27 | — | — | EP | claimed |
| WO-2006049599-A1 | METHODS OF DETECTION AND THERAPY FOR ATHEROMATOUS PLAQUES USING IMMUNE MODULATION | THE GENERAL HOSPITAL CORPORATION (US) | 2006-05-11 | — | — | WO | claimed |
| EP-1140166-A2 | NOVEL ADJUVANT FOR SUBUNIT OR COMPONENT VACCINES | VIROGENETICS CORPORATION (US) | 2001-10-10 | — | — | EP | claimed |
| WO-2000035482-A2 | NOVEL ADJUVANT FOR SUBUNIT OR COMPONENT VACCINES | VIROGENETICS CORPORATION (US) | 2000-06-22 | — | — | WO | claimed |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-04-25 | — | — | US | disclosed |
| CN-116731181-B | Anti-human CD10 protein rabbit monoclonal antibody and application thereof | 武汉爱博泰克生物科技有限公司 | 2024-01-12 | — | — | CN | disclosed |
| WO-2023230593-A1 | PTP1B INHIBITORS FOR TREATING LUNG INJURY | COLD SPRING HARBOR LABORATORY (US) | 2023-11-30 | — | — | WO | disclosed |
| CN-116731181-A | Anti-human CD10 protein rabbit monoclonal antibody and application thereof | 武汉爱博泰克生物科技有限公司 | 2023-09-12 | — | — | CN | disclosed |
| US-20220047698-A1 | SYNTHETIC INNATE IMMUNE RECEPTOR LIGANDS AND USES THEREOF | ALBERTA RES CHEMICALS INC (CA) | 2022-02-17 | — | — | US | disclosed |
| US-20210161980-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-06-03 | — | — | US | disclosed |
| US-5595737-A | Methods for using monoclonal antibodies specific for cell-surface bound LAM-1 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0633785-A4 | SPECIFIC DETECTION OF CELL SURFACE RECEPTOR LEUKOCYTE ADHESION MOLECULE-1. | DANA FARBER CANCER INST INC (US) | 1995-04-05 | — | — | EP | disclosed |
| US-5389520-A | Specific detection of cell surface receptor leukocyte adhesion molecule-1 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1995-02-14 | — | — | US | disclosed |
| EP-0633785-A1 | SPECIFIC DETECTION OF CELL SURFACE RECEPTOR LEUKOCYTE ADHESION MOLECULE-1 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993019782-A1 | SPECIFIC DETECTION OF CELL SURFACE RECEPTOR LEUKOCYTE ADHESION MOLECULE-1 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1993-10-14 | — | — | WO | disclosed |
| EP-0463116-A4 | IMAGING TISSUE SITES OF INFLAMMATION | — | 1992-02-19 | — | — | EP | disclosed |
| EP-0463116-A1 | IMAGING TISSUE SITES OF INFLAMMATION | NEORX CORPORATION (US) | 1992-01-02 | — | — | EP | disclosed |
| WO-1990010463-A1 | IMAGING TISSUE SITES OF INFLAMMATION | NEORX CORPORATION (US) | 1990-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | SLC7A5 4010/4885ALPI 4037/4885PKM 3213/4885 |
| US-20210161980-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | SLC7A5 4010/4885ALPI 4037/4885PKM 3213/4885 |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | SLC7A5 4010/4885ALPI 4037/4885PKM 3213/4885 |
| US-20220047698-A1 | SYNTHETIC INNATE IMMUNE RECEPTOR LIGANDS AND USES THEREOF | TLR3, TLR4, TLR9 | SLC7A5 2711/4885ALPI 2378/4885PKM 1332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.